Crossmark

How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses

Crossref DOI link: https://doi.org/10.1186/s12955-024-02293-4

Published Online: 2024-09-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abel, Lucy

Dakin, Helen

Cai, Ting

McManus, Richard J.

McNiven, Abigail

Rivero-Arias, Oliver
Funding

Funding for this research was provided by:

Wellcome (217826/Z/19/Z)

NIHR Oxford and Thames Valley Applied Research Consortium

NIHR Senior Investigator

Oliver Bird Fund Nuffield Foundation (OBF/43985)

NIHR Policy Research Programme (NIHR202450)
License Information

Text and Data Mining valid from 2024-09-11

Version of Record valid from 2024-09-11
More Information

Article History

Received: 6 June 2024

Accepted: 28 August 2024

First Online: 11 September 2024

Declarations

:

: Not applicable.

: Not applicable.

: ORA is an Editor of Health and Quality of Life Outcomes. The other authors declare that they have no competing interests.

Document is current

Any future updates will be listed below